On this week's special episode, we will hear from experts in arthroscopy and surgery including content from:Chris Vertullo and Teppo Järvinen - Should I have an arthroscopy for my knee arthritis? (Season 1, Episode 9)Howard Luks - Do you really need surgery for your knee osteoarthritis? (Season 2, Episode 20)Teppo Järvinen - Arthroscopy, past time to stop the harm (Season 4, Episode 4) CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

The prevalence of osteoarthritis is increasing as are rates of overweight and obesity. Overweight and obesity are both important risk factors for the onset and progression of knee osteoarthritis.Weight loss is an effective treatment for osteoarthritis and has been shown to reduce pain and improve function – but what about structural changes? On this week’s podcast, Zübeyir Salis joins us to discuss this important topic.RESOURCESAssociation of Decrease in Body Mass Index With Reduced Incidence and Progression of the Structural Defects of Knee Osteoarthritis: A Prospective Multi-Cohort StudyCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Osteoarthritis (OA) is the most common form of arthritis. There are currently no effective disease-modifying treatments available to slow or reverse the progression of OA. Drugs such as metformin, which is commonly used to treat type 2 diabetes are generally safe and low cost. Research has been shown that metformin has anti-inflammatory and pro-weight loss effects, suggesting that the use of metformin may be useful in the treatment or prevention of OA. Dr Matthew Baker joins us on this week's episode of Joint Action to discuss this important topic. Dr. Matthew Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, and rheumatoid arthritis. In addition, he is the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program and collaborates with other team members to advance sarcoidosis clinical care and research.RESOURCESDevelopment of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a SulfonylureaIncreased risk of osteoarthritis in patients with atopic diseaseCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Viscosupplementation is a procedure that involves injections of hyaluronic acid, most commonly into the knee joint. In the United States, one in every seven people receive a hyaluronic acid injection as first line treatment for their knee osteoarthritis. However, the effectiveness and safety of viscosupplementation has remained controversial. On this week’s episode of Joint Action, we are joined by Bruno da Costa to discuss viscosupplementation, their effectiveness and safety.Dr. Bruno R. da Costa is Deputy Director of Trial Methodology Program at Nuffield Department of Population Health, University of Oxford, and Associate Professor of Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation, University of Toronto. He has a Ph.D. in Clinical Epidemiology and Biostatistics from the University of Bern in Switzerland, a M.Sc. in Medical Statistics from the University of Leicester in the UK, and a M.Sc. in Physical Therapy from the University of Alberta in Canada. Dr. da Costa is considered to be an influential scientist in the field of musculoskeletal and cardiovascular disease and methodological research on comparative effectiveness. He has co-authored over 100 scholarly peer-reviewed publications, which have been published in prominent peer-reviewed scientific journals such as The New England Journal of Medicine, The Lancet, Journal of the American Medical Association (JAMA), and The BMJ.RESOURCESViscosupplementation for knee osteoarthritis: systematic review and meta-analysisCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Experts in pain management and osteoarthritis delve into the complexities of joint pain and pain sensation. They discuss the varied experiences and patterns of pain in osteoarthritis patients, challenging misconceptions and advocating for holistic treatment approaches.

Although joint replacement surgery is an effective treatment for end-stage osteoarthritis, they are not appropriate for everyone. Factors such as age, overall health and the severity of osteoarthritis must be considered when making decisions about joint replacement surgery. By selecting appropriate patients for joint replacement surgery, we can ensure that the procedure remains a safe and effective option for improving the quality of life for those living with osteoarthritis.On this week’s podcast, Prof Gillian Hawker joins us to discuss this important topic.Gillian Hawker is Professor of Medicine in the Department of Medicine, Division of Rheumatology, at the University of Toronto. She is active staff in Rheumatology at Women’s College Hospital, where she is a clinician-scientist at the Women’s College Research Institute. She is a senior scientist at the Institute for Health Policy, Management and Evaluation and adjunct senior scientist at the Institute for Clinical Evaluative Sciences. In July 2014, she was appointed the Sir John and Lady Eaton Professor and Chair of the Department of Medicine at the University of Toronto (U of T).RESOURCESInstruments to assess appropriateness of hip and knee arthroplasty: a systematic reviewThe crux of the issue: assessment of patient appropriateness for joint replacement requires a conversation with the patientCONNECT WITH GILLIANTwitter: @UofTDoMChairEmail: g.hawker@utoronto.caCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

We have spoken about occupational risk factors for osteoarthritis on previous episodes, but one occupation we have not covered is elite level athletes or Olympians. The intense training schedules sometimes lasting up to 6 hours a day make Olympians more susceptible to joint injury. On this week’s episode of Joint Action, we are joined by Dr Debbie Palmer to discuss the prevalence of osteoarthritis in Olympians. Dr Debbie Palmer OLY is a lecturer in research methods and epidemiology. She is a three-time Winter Olympian, and competed in short track speed skating between 1990-2002. Debbie subsequently worked as an exercise physiologist at the University of Bath before completing her PhD in injury epidemiology 2009, and she has worked in sport injury and illness prevention for over 14 years. Debbie’s research focuses on epidemiology, risk and prevention of injury and illness in elite, youth and recreational cohorts, longer-term consequences of sport-related injury, and current and retired athlete health.RESOURCESPrevalence of and factors associated with osteoarthritis and pain in retired Olympians compared with the general population: part 1 – the lower limbPrevalence of and factors associated with osteoarthritis and pain in retired Olympians compared with the general population: part 2 – the spine and upper limbConsequences of injury are greater for Olympians than the general populationCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Prof Melanie Holden, a Chartered Physiotherapist specializing in osteoarthritis treatment through exercise, discusses the benefits of exercise for knee and hip osteoarthritis patients. Topics include challenges in optimal exercise delivery, personalized exercise prescriptions, the positive impacts of exercise on physical and mental health, and the importance of clarity in prescribing appropriate exercises for osteoarthritis patients.

About 50% of people who have an anterior cruciate ligament (ACL) injury will go on to develop osteoarthritis later down the track. What determines who will go on to develop OA? And is it possible to reduce your risk of developing OA? On this week’s episode, Dr Adam Culvenor joins us to discuss.Dr Adam Culvenor is a Senior Research Fellow and Head of the Anterior Cruciate Ligament (ACL) Knee Injury Group within the La Trobe Sport and Exercise Medicine Research Centre. His research focuses on the outcomes of ACL injuries, in particular the prevention and management of early knee osteoarthritis in young adults following ACL injury and reconstruction.RESOURCESWebsitesLaTrobe University Sport and Exercise Medicine Research Centre BlogThe OPTIKNEE group is working to prevent osteoarthritis after knee injuryJournal articlesOPTIKNEE 2022: consensus recommendations to optimise knee health after traumatic knee injury to prevent osteoarthritisKnee Extensor Strength and Risk of Structural, Symptomatic, and Functional Decline in Knee Osteoarthritis: A Systematic Review and Meta-AnalysisEarly Knee Osteoarthritis Is Evident One Year Following Anterior Cruciate Ligament Reconstruction: A Magnetic Resonance Imaging EvaluationCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Over the years, there has been good evidence that certain treatments are of little or no value, provide harm and have substantial costs associated with them. Arthroscopic partial meniscectomy (APM) is not a recommended treatment for osteoarthritis. Despite this, millions of these procedures are still being performed each year. On this week's episode of Joint Action we are joined by Professor Teppo Järvinen to discuss the evidence behind APM and evidence-based medicine.Professor Teppo Järvinen, an orthopaedic surgeon at the department of orthopaedics and trauma at Helsinki University and Helsinki University Central Hospital. Teppo led the Fidelity trial and has a strong interest in the “too much medicine” movement.CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.